In a new ray of hope in the Coronavirus vaccine development, Covaxin developed by AstraZeneca and Oxford University has successfully triggered a strong immune response.
Now, Covaxin has successfully entered phase 3 of trial.
In a new ray of hope in the Coronavirus vaccine development, Covaxin developed by AstraZeneca and Oxford University has successfully triggered a strong immune response.
Now, Covaxin has successfully entered phase 3 of trial.
Next Post